Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Blane Fillingim
- Brian Post
- Lauren Heinrich
- Peeyush Nandwana
- Sudarsanam Babu
- Thomas Feldhausen
- Yousub Lee
- Annetta Burger
- Bruce Moyer
- Carter Christopher
- Chance C Brown
- Debjani Pal
- Debraj De
- Gautam Malviya Thakur
- James Gaboardi
- Jeffrey Einkauf
- Jennifer M Pyles
- Jesse McGaha
- Justin Griswold
- Kevin Sparks
- Kuntal De
- Laetitia H Delmau
- Liz McBride
- Luke Sadergaski
- Mike Zach
- Padhraic L Mulligan
- Ramanan Sankaran
- Sandra Davern
- Todd Thomas
- Vimal Ramanuj
- Wenjun Ge
- Xiuling Nie

Often there are major challenges in developing diverse and complex human mobility metrics systematically and quickly.

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

This work seeks to alter the interface condition through thermal history modification, deposition energy density, and interface surface preparation to prevent interface cracking.

Additive manufacturing (AM) enables the incremental buildup of monolithic components with a variety of materials, and material deposition locations.

Ceramic matrix composites are used in several industries, such as aerospace, for lightweight, high quality and high strength materials. But producing them is time consuming and often low quality.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence